Main > GENETIC DISEASES (*) > Amyloidosis TransThyRetin Poly>* > Treatment > Co: USA. A. Inotersen Na Inj.

---

Co: USA. A. Inotersen Na Inj.'s subsections
(*) CA Approval Date: 2018. 10.04.
(*) EU Approval Date: 2018. 07.11.
(*) USA Approval Date: 2018. 10.05.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 10.09.
TradeMark
TradeMark Web-Site EU
TradeMark Web-Site USA

Co: USA. A. Inotersen Na Inj.'s products
This section has no products